Top compounds associated with response to LYPD1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	JW-7-24-1	GDSC1000	pan-cancer	AAC	-0.0074	0.8
mRNA	leptomycin B	CTRPv2	pan-cancer	AAC	0.0087	0.8
mRNA	dabrafenib	GDSC1000	pan-cancer	AAC	0.0074	0.8
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0089	0.8
mRNA	masitinib	GDSC1000	pan-cancer	AAC	0.0078	0.8
mRNA	JNJ-26854165	GDSC1000	pan-cancer	AAC	0.0082	0.8
mRNA	selumetinib:JQ-1 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.0087	0.8
mRNA	Vandetanib	CCLE	pan-cancer	AAC	-0.013	0.8
mRNA	Bicalutamide	GDSC1000	pan-cancer	AAC	0.0081	0.8
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0091	0.8

Download CSV